Merck ($MRK) prevails in appeals court on Temodar patent

Merck's ($MRK) Schering-Plough unit won an appeals court ruling that revives its effort to block Teva Pharmaceutical Industries ($TEVA) from selling a generic form of the brain-cancer drug Temodar until 2013. Report